|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.31 SEK | +33.62% |
|
+32.76% | +2.31% |
Stayble Therapeutics AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was SEK 0.286 million compared to SEK 0.009 million a year ago. Net loss was SEK 24.53 million compared to SEK 12.09 million a year ago.
Basic loss per share from continuing operations was SEK 1.77 compared to SEK 0.87 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.31% | 910K | |
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +6.79% | 14.16B | |
| +38.61% | 12.63B |
STAYBLE THERAPEUTICS AB 
